The best time to start Mounjaro — and what that decision actually involves

You've decided to look into this, so what's actually stopping you?

Most people who search 'best time to start Mounjaro' have already spent weeks thinking about it. They've read about the trial results, they've watched the price shift, and they have one question underneath all the research: is now the right time for me specifically? That's a fair question. It deserves a straight answer.

Clinically, the timing decision rests on a few concrete things. Your BMI needs to sit at 30 or above, or at 27 or above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes or obstructive sleep apnoea. Those figures come from the licensed criteria in Mounjaro's UK Summary of Product Characteristics, and they're the baseline a prescriber checks first. Below that threshold, the medicine is not licensed for you, and a responsible prescriber won't proceed.

Beyond BMI, your current medicines matter. If you take oral contraceptives, for example, NHS guidance advises adding a non-oral method of contraception for the first four weeks of treatment and for four weeks after each dose increase, because tirzepatide slows gastric emptying in a way that can affect how oral medicines are absorbed. That's not a reason to put things off, it's a reason to flag it at consultation so a plan is in place before day one. You can find a detailed overview of how tirzepatide works and what it interacts with if you want more context before your assessment.

Why 'I'll start after the holidays' is usually the wrong frame

A pattern our prescribers see regularly: people who delay starting because they want a 'clean' run, no Christmas dinners, no weddings, no travel. The logic is understandable. It's also, in most cases, a way of asking tirzepatide to compete with a perfect lifestyle rather than support an ordinary one.

The clinical trials that established Mounjaro's results (including SURMOUNT-1, published in the New England Journal of Medicine, which enrolled 2,539 adults and showed an average body-weight reduction of around 20 to 21% at the 15 mg dose over 72 weeks) were not conducted under laboratory-perfect conditions. Participants had social lives. The evidence holds across real human variation.

What does matter practically is the weekly rhythm. You inject once a week, on the same day each week. Choosing that day thoughtfully at the start (one where you're unlikely to be travelling or unusually rushed) makes the habit easier to sustain. There's more detail on choosing the right day to begin if you want to think that through specifically. The short version: any consistent day works; inconsistency is the only problem.

If you're considering the cost side of things before committing, the Mounjaro price comparison page sets out the UK private market context honestly, including what a single transparent price should cover.

Situations where a prescriber will want to talk timing carefully

There are genuine circumstances where starting now, rather than after a conversation, would be premature. None of them should be embarrassing to raise, they're exactly what a clinical consultation is for.

Planned surgery is one. NHS England advises telling your anaesthetist and surgical team that you are taking a GLP-1 medicine before any procedure. If you have an operation scheduled in the near term, your prescriber will factor that in. It doesn't automatically mean waiting, but it means the surgical team needs to know, and the timing of doses around the procedure may need adjusting, something your prescriber handles, not something you manage from the leaflet alone. The step-by-step guide to starting Mounjaro covers what to expect in those first weeks.

Pregnancy and breastfeeding are clear contraindications: Mounjaro is not recommended during pregnancy, while breastfeeding, or if you are actively trying to conceive. Women who are not trying to conceive should have reliable contraception in place before starting. Under-18s are outside the licensed indication entirely.

A history of pancreatitis, medullary thyroid carcinoma or MEN2 are conditions a prescriber assesses carefully before prescribing. So are certain gastrointestinal conditions. Raising these upfront saves time and keeps the process safe. The Mounjaro treatment overview has a fuller summary of conditions that require prescriber discussion. The NHS also maintains a clear patient-level guide at nhs.uk/medicines/tirzepatide covering contraindications, storage and what to expect.

What happens once the clinical timing is right

Once a prescriber has confirmed suitability, the practical side is straightforward. At nume, consultations are reviewed the same day by a GPhC-registered Independent Prescriber, a real clinician reads your answers, not software. Order before 12pm Monday to Friday and, once approved, treatment is dispatched the same day. A DPD tracking notification arrives on your phone; the box itself is plain and unbranded. Inside is your first KwikPen: the 2.5 mg starter pen that begins the gradual titration schedule your prescriber sets out.

That first pen's job is adjustment, not dramatic effect. It takes a few weeks for your system to settle, and the therapeutic dose comes later in the schedule, at the pace your prescriber decides is appropriate for you. For practical questions about injection timing within the day, the page on what time of day to take your Mounjaro shot is worth reading before your first injection. And if you're unsure how much flexibility exists between doses, the guidance on spacing between injections explains what the prescribing information actually allows.

The right time to start is when the clinical picture is clear and a prescriber has said yes. That process begins with a free consultation through our treatment page, no commitment, just the clinical conversation that makes everything else possible.